TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs4675874
log Bayes Factor = 0.00424198
Chromosome 2   position 241,819,796  (GRCh37) Explore rs4675874 on Ensembl!
Variant rs4675874 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
M81.99 Osteoporosis, unspecified (Site unspecified)
0.098 0.902 0.000
M81.9 Osteoporosis, unspecified
0.083 0.917 0.000
M81.95 Osteoporosis, unspecified (Pelvic region and thigh)
0.080 0.920 0.000
G56.0 Carpal tunnel syndrome
0.000 0.932 0.068
M81.96 Osteoporosis, unspecified (Lower leg)
0.066 0.934 0.000
M81.97 Osteoporosis, unspecified (Ankle and foot)
0.066 0.934 0.000
M81.92 Osteoporosis, unspecified (Upper arm)
0.059 0.940 0.000
M81.93 Osteoporosis, unspecified (Forearm)
0.059 0.941 0.000
M81.94 Osteoporosis, unspecified (Hand)
0.054 0.946 0.000
M81.91 Osteoporosis, unspecified (Shoulder region)
0.052 0.947 0.000
M81.98 Osteoporosis, unspecified (Other)
0.053 0.947 0.000
M81.90 Osteoporosis, unspecified (Multiple sites)
0.045 0.955 0.000
M81 Osteoporosis without pathological fracture
0.040 0.960 0.000
M81.8 Other osteoporosis
0.032 0.968 0.000
M81.1 Postoophorectomy osteoporosis
0.031 0.968 0.000
M81.6 Localised osteoporosis [Lequesne]
0.029 0.971 0.000
M81.5 Idiopathic osteoporosis
0.029 0.971 0.000
G56 Mononeuropathies of upper limb
0.000 0.972 0.028
M81.4 Drug-induced osteoporosis
0.028 0.972 0.000
M81.0 Postmenopausal osteoporosis
0.028 0.972 0.000
M81.2 Osteoporosis of disuse
0.027 0.973 0.000
N81.2 Incomplete uterovaginal prolapse
0.027 0.973 0.000
M81.80 Other osteoporosis (Multiple sites)
0.026 0.974 0.000
M81.3 Postsurgical malabsorption osteoporosis
0.025 0.974 0.000
M81.10 Postoophorectomy osteoporosis (Multiple sites)
0.025 0.975 0.000
C83.3 Large cell (diffuse)
0.000 0.975 0.025
G56.8 Other mononeuropathies of upper limb
0.000 0.976 0.024
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.976 0.024
M81.49 Drug-induced osteoporosis (Site unspecified)
0.024 0.976 0.000
M81.89 Other osteoporosis (Site unspecified)
0.023 0.977 0.000
M81.88 Other osteoporosis (Other)
0.023 0.977 0.000
M81.87 Other osteoporosis (Ankle and foot)
0.023 0.977 0.000
M81.86 Other osteoporosis (Lower leg)
0.023 0.977 0.000
M81.85 Other osteoporosis (Pelvic region and thigh)
0.023 0.977 0.000
M81.84 Other osteoporosis (Hand)
0.023 0.977 0.000
M81.83 Other osteoporosis (Forearm)
0.023 0.977 0.000
M81.82 Other osteoporosis (Upper arm)
0.023 0.977 0.000
M81.81 Other osteoporosis (Shoulder region)
0.023 0.977 0.000
M81.19 Postoophorectomy osteoporosis (Site unspecified)
0.023 0.977 0.000
M81.18 Postoophorectomy osteoporosis (Other)
0.023 0.977 0.000
M81.17 Postoophorectomy osteoporosis (Ankle and foot)
0.023 0.977 0.000
M81.16 Postoophorectomy osteoporosis (Lower leg)
0.023 0.977 0.000
M81.15 Postoophorectomy osteoporosis (Pelvic region and thigh)
0.023 0.977 0.000
M81.14 Postoophorectomy osteoporosis (Hand)
0.023 0.977 0.000
M81.13 Postoophorectomy osteoporosis (Forearm)
0.023 0.977 0.000
M81.12 Postoophorectomy osteoporosis (Upper arm)
0.023 0.977 0.000
M81.11 Postoophorectomy osteoporosis (Shoulder region)
0.023 0.977 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.978 0.022
G56.9 Mononeuropathy of upper limb, unspecified
0.000 0.979 0.021
M81.59 Idiopathic osteoporosis (Site unspecified)
0.021 0.979 0.000
M81.58 Idiopathic osteoporosis (Other)
0.021 0.979 0.000
M81.57 Idiopathic osteoporosis (Ankle and foot)
0.021 0.979 0.000
M81.56 Idiopathic osteoporosis (Lower leg)
0.021 0.979 0.000
M81.55 Idiopathic osteoporosis (Pelvic region and thigh)
0.021 0.979 0.000
M81.54 Idiopathic osteoporosis (Hand)
0.021 0.979 0.000
M81.53 Idiopathic osteoporosis (Forearm)
0.021 0.979 0.000
M81.52 Idiopathic osteoporosis (Upper arm)
0.021 0.979 0.000
M81.51 Idiopathic osteoporosis (Shoulder region)
0.021 0.979 0.000
M81.50 Idiopathic osteoporosis (Multiple sites)
0.021 0.979 0.000
M81.69 Localized osteoporosis [Lequesne] (Site unspecified)
0.021 0.979 0.000
M81.68 Localized osteoporosis [Lequesne] (Other)
0.021 0.979 0.000
M81.67 Localized osteoporosis [Lequesne] (Ankle and foot)
0.021 0.979 0.000
M81.66 Localized osteoporosis [Lequesne] (Lower leg)
0.021 0.979 0.000
M81.65 Localized osteoporosis [Lequesne] (Pelvic region and thigh)
0.021 0.979 0.000
M81.64 Localized osteoporosis [Lequesne] (Hand)
0.021 0.979 0.000
M81.63 Localized osteoporosis [Lequesne] (Forearm)
0.021 0.979 0.000
M81.62 Localized osteoporosis [Lequesne] (Upper arm)
0.021 0.979 0.000
M81.61 Localized osteoporosis [Lequesne] (Shoulder region)
0.021 0.979 0.000
M81.60 Localized osteoporosis [Lequesne] (Multiple sites)
0.021 0.979 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.979 0.021
C92.0 Acute myeloid leukaemia
0.000 0.979 0.021
M81.48 Drug-induced osteoporosis (Other)
0.020 0.980 0.000
M81.47 Drug-induced osteoporosis (Ankle and foot)
0.020 0.980 0.000
M81.46 Drug-induced osteoporosis (Lower leg)
0.020 0.980 0.000
M81.45 Drug-induced osteoporosis (Pelvic region and thigh)
0.020 0.980 0.000
M81.44 Drug-induced osteoporosis (Hand)
0.020 0.980 0.000
M81.43 Drug-induced osteoporosis (Forearm)
0.020 0.980 0.000
M81.42 Drug-induced osteoporosis (Upper arm)
0.020 0.980 0.000
M81.41 Drug-induced osteoporosis (Shoulder region)
0.020 0.980 0.000
M81.08 Postmenopausal osteoporosis (Other)
0.020 0.980 0.000
M81.07 Postmenopausal osteoporosis (Ankle and foot)
0.020 0.980 0.000
M81.06 Postmenopausal osteoporosis (Lower leg)
0.020 0.980 0.000
M81.05 Postmenopausal osteoporosis (Pelvic region and thigh)
0.020 0.980 0.000
M81.04 Postmenopausal osteoporosis (Hand)
0.020 0.980 0.000
M81.03 Postmenopausal osteoporosis (Forearm)
0.020 0.980 0.000
M81.02 Postmenopausal osteoporosis (Upper arm)
0.020 0.980 0.000
M81.01 Postmenopausal osteoporosis (Shoulder region)
0.020 0.980 0.000
M81.00 Postmenopausal osteoporosis (Multiple sites)
0.020 0.980 0.000
G56.3 Lesion of radial nerve
0.000 0.980 0.020
C83.7 Burkitt's tumour
0.000 0.980 0.020
G56.2 Lesion of ulnar nerve
0.000 0.980 0.020
M81.29 Osteoporosis of disuse (Site unspecified)
0.019 0.980 0.000
M81.28 Osteoporosis of disuse (Other)
0.019 0.980 0.000
M81.27 Osteoporosis of disuse (Ankle and foot)
0.019 0.980 0.000
M81.26 Osteoporosis of disuse (Lower leg)
0.019 0.980 0.000
M81.25 Osteoporosis of disuse (Pelvic region and thigh)
0.019 0.980 0.000
M81.24 Osteoporosis of disuse (Hand)
0.019 0.980 0.000
M81.23 Osteoporosis of disuse (Forearm)
0.019 0.980 0.000
M81.22 Osteoporosis of disuse (Upper arm)
0.019 0.980 0.000
M81.21 Osteoporosis of disuse (Shoulder region)
0.019 0.980 0.000
C92 Myeloid leukaemia
0.000 0.980 0.020
G56.4 Causalgia
0.000 0.981 0.019
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.981 0.019
M81.09 Postmenopausal osteoporosis (Site unspecified)
0.019 0.981 0.000
M81.39 Postsurgical malabsorption osteoporosis (Site unspecified)
0.018 0.981 0.000
M81.38 Postsurgical malabsorption osteoporosis (Other)
0.018 0.981 0.000
M81.37 Postsurgical malabsorption osteoporosis (Ankle and foot)
0.018 0.981 0.000
M81.36 Postsurgical malabsorption osteoporosis (Lower leg)
0.018 0.981 0.000
M81.35 Postsurgical malabsorption osteoporosis (Pelvic region and thigh)
0.018 0.981 0.000
M81.34 Postsurgical malabsorption osteoporosis (Hand)
0.018 0.981 0.000
M81.33 Postsurgical malabsorption osteoporosis (Forearm)
0.018 0.981 0.000
M81.32 Postsurgical malabsorption osteoporosis (Upper arm)
0.018 0.981 0.000
M81.31 Postsurgical malabsorption osteoporosis (Shoulder region)
0.018 0.981 0.000
G56.1 Other lesions of median nerve
0.000 0.982 0.018
Y43.3 Other antineoplastic drugs
0.000 0.983 0.017
C83.0 Small cell (diffuse)
0.000 0.983 0.017
C83.6 Undifferentiated (diffuse)
0.000 0.983 0.017
C83.4 Immunoblastic (diffuse)
0.000 0.983 0.017
C83.2 Mixed small and large cell (diffuse)
0.000 0.983 0.017
C83.1 Small cleaved cell (diffuse)
0.000 0.983 0.017
M81.20 Osteoporosis of disuse (Multiple sites)
0.017 0.983 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.983 0.017
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.983 0.017
C95 Leukaemia of unspecified cell type
0.000 0.983 0.017
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.984 0.016
C92.5 Acute myelomonocytic leukaemia
0.000 0.984 0.016
C86 Other specified types of T/NK-cell lymphoma
0.000 0.984 0.016
C83.5 Lymphoblastic (diffuse)
0.000 0.984 0.016
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.984 0.016
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.984 0.016
C92.9 Myeloid leukaemia, unspecified
0.000 0.984 0.016
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.984 0.015
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.985 0.015
M81.30 Postsurgical malabsorption osteoporosis (Multiple sites)
0.015 0.985 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.985 0.015
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.985 0.015
C95.9 Leukaemia, unspecified
0.000 0.985 0.015
C81 Hodgkin's disease
0.000 0.985 0.015
C88 Malignant immunoproliferative diseases
0.000 0.985 0.014
C92.2 Subacute myeloid leukaemia
0.000 0.985 0.014
C94 Other leukaemias of specified cell type
0.000 0.986 0.014
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.986 0.014
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.986 0.014
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.986 0.014
C92.3 Myeloid sarcoma
0.000 0.986 0.014
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.986 0.014
M80-M85 Disorders of bone density and structure
0.014 0.986 0.000
T42.4 Benzodiazepines
0.000 0.986 0.014
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.986 0.014
C92.7 Other myeloid leukaemia
0.000 0.986 0.014
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.986 0.014
T43.2 Other and unspecified antidepressants
0.000 0.986 0.014
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.986 0.014
C92.4 Acute promyelocytic leukaemia
0.000 0.987 0.013
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.987 0.013
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.987 0.013
C93 Monocytic leukaemia
0.000 0.987 0.013
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.987 0.013
M85 Other disorders of bone density and structure
0.013 0.987 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.988 0.012
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.988 0.012
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.988 0.012
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.988 0.012
C81.0 Lymphocytic predominance
0.000 0.988 0.012
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.988 0.012
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.988 0.012
M81.40 Drug-induced osteoporosis (Multiple sites)
0.012 0.988 0.000
C95.7 Other leukaemia of unspecified cell type
0.000 0.988 0.012
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.988 0.012
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.988 0.012
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.988 0.012
C84.4 Peripheral T-cell lymphoma
0.000 0.988 0.012
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.988 0.012
T42.0 Hydantoin derivatives
0.000 0.988 0.012
C81.2 Mixed cellularity
0.000 0.988 0.012
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.988 0.012
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.988 0.012
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.988 0.012
C86.4 Blastic NK-cell lymphoma
0.000 0.988 0.012
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.988 0.012
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.988 0.012
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.988 0.012
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.988 0.012
C95.0 Acute leukaemia of unspecified cell type
0.000 0.988 0.011
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.988 0.011
T42.2 Succinimides and oxazolidinediones
0.000 0.988 0.011
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.988 0.011
T42.1 Iminostilbenes
0.000 0.989 0.011
C81.7 Other Hodgkin's disease
0.000 0.989 0.011
C91 Lymphoid leukaemia
0.000 0.989 0.011
T43.9 Psychotropic drug, unspecified
0.000 0.989 0.011
T50.7 Analeptics and opioid receptor antagonists
0.000 0.989 0.011
T50.5 Appetite depressants
0.000 0.989 0.011
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.989 0.011
T50.0 Mineralocorticoids and their antagonists
0.000 0.989 0.011
T36 Poisoning by systemic antibiotics
0.000 0.989 0.011
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.989 0.011
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.989 0.011
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.989 0.011
T50.8 Diagnostic agents
0.000 0.989 0.011
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.989 0.011
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.989 0.011
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.989 0.011
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.989 0.011
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.989 0.011
T44.0 Anticholinesterase agents
0.000 0.989 0.011
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.989 0.011
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.989 0.011
T50.1 Loop [high-ceiling] diuretics
0.000 0.989 0.011
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.989 0.011
C81.3 Lymphocytic depletion
0.000 0.989 0.011
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.989 0.011
C88.7 Other malignant immunoproliferative diseases
0.000 0.989 0.011
C88.3 Immunoproliferative small intestinal disease
0.000 0.989 0.011
C88.2 Gamma heavy chain disease
0.000 0.989 0.011
C88.1 Alpha heavy chain disease
0.000 0.989 0.011
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.989 0.011
M85.6 Other cyst of bone
0.011 0.989 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.989 0.011
C94.7 Other specified leukaemias
0.000 0.989 0.010
C94.5 Acute myelofibrosis
0.000 0.989 0.010
C94.4 Acute panmyelosis
0.000 0.989 0.010
C94.3 Mast cell leukaemia
0.000 0.989 0.010
C94.2 Acute megakaryoblastic leukaemia
0.000 0.989 0.010
C94.1 Chronic erythraemia
0.000 0.989 0.010
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.989 0.010
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.989 0.010
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.989 0.010
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.989 0.010
C84.3 Lymphoepithelioid lymphoma
0.000 0.989 0.010
C84.2 T-zone lymphoma
0.000 0.989 0.010
C84.1 Sezary's diease
0.000 0.989 0.010
T43.6 Psychostimulants with abuse potential
0.000 0.989 0.010
C84.0 Mycosis fungoides
0.000 0.989 0.010
M85.2 Hyperostosis of skull
0.010 0.989 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.989 0.010
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.990 0.010
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.990 0.010
T46.7 Peripheral vasodilators
0.000 0.990 0.010
T42.3 Barbiturates
0.000 0.990 0.010
C91.4 Hairy-cell leukaemia
0.000 0.990 0.010
C82.3 Follicular lymphoma grade IIIa
0.000 0.990 0.010
C81.1 Nodular sclerosis
0.000 0.990 0.010
C84.5 Other and unspecified T-cell lymphomas
0.000 0.990 0.010
T46.1 Calcium-channel blockers
0.000 0.990 0.010
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.990 0.010
C96.8 Histiocytic sarcoma
0.000 0.990 0.010
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.990 0.010
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.990 0.010
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.990 0.010
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.990 0.010
C96.3 True histiocytic lymphoma
0.000 0.990 0.010
C96.2 Malignant mast cell tumour
0.000 0.990 0.010
C96.1 Malignant histiocytosis
0.000 0.990 0.010
C96.0 Letterer-Siwe disease
0.000 0.990 0.010
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.990 0.010
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.990 0.010
Z51.1 Chemotherapy session for neoplasm
0.000 0.990 0.010
M83 Adult osteomalacia
0.010 0.990 0.000
M85.9 Disorder of bone density and structure, unspecified
0.010 0.990 0.000
M80 Osteoporosis with pathological fracture
0.010 0.990 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.990 0.010
M85.8 Other specified disorders of bone density and structure
0.010 0.990 0.000
M85.0 Fibrous dysplasia (monostotic)
0.010 0.990 0.000
C92.1 Chronic myeloid leukaemia
0.000 0.990 0.009
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.990 0.010
C82.0 Small cleaved cell, follicular
0.000 0.990 0.009
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.991 0.009
C93.9 Monocytic leukaemia, unspecified
0.000 0.991 0.009
C93.7 Other monocytic leukaemia
0.000 0.991 0.009
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.991 0.009
C93.2 Subacute monocytic leukaemia
0.000 0.991 0.009
C93.0 Acute monocytic leukaemia
0.000 0.991 0.009
M82 Osteoporosis in diseases classified elsewhere
0.009 0.991 0.000
M85.65 Other cyst of bone (Pelvic region and thigh)
0.009 0.991 0.000
M85.5 Aneurysmal bone cyst
0.009 0.991 0.000
M85.3 Osteitis condensans
0.009 0.991 0.000
M85.1 Skeletal fluorosis
0.009 0.991 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.991 0.009
C82.6 Cutaneous follicle centre lymphoma
0.000 0.991 0.009
C82.5 Diffuse follicle centre lymphoma
0.000 0.991 0.009
C82.4 Follicular lymphoma grade IIIb
0.000 0.991 0.009
T50.4 Drugs affecting uric acid metabolism
0.000 0.991 0.009
T49.9 Topical agent, unspecified
0.000 0.991 0.009
T49.8 Other topical agents
0.000 0.991 0.009
T49.7 Dental drugs, topically applied
0.000 0.991 0.009
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.991 0.009
T49.5 Ophthalmological drugs and preparations
0.000 0.991 0.009
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.991 0.009
T49.3 Emollients, demulcents and protectants
0.000 0.991 0.009
T49.2 Local astringents and local detergents
0.000 0.991 0.009
T49.1 Antipruritics
0.000 0.991 0.009
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.991 0.009
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.991 0.009
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.991 0.009
T48.4 Expectorants
0.000 0.991 0.009
T48.3 Antitussives
0.000 0.991 0.009
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.991 0.009
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.991 0.009
T48.0 Oxytocic drugs
0.000 0.991 0.009
C85.1 B-cell lymphoma, unspecified
0.000 0.991 0.009
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.991 0.009
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.991 0.009
M85.67 Other cyst of bone (Ankle and foot)
0.009 0.991 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.991 0.009
T37.5 Antiviral drugs
0.000 0.991 0.009
T37.4 Anthelminthics
0.000 0.991 0.009
T37.3 Other antiprotozoal drugs
0.000 0.991 0.009
T37.1 Antimycobacterial drugs
0.000 0.991 0.009
T37.0 Sulphonamides
0.000 0.991 0.009
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.991 0.008
M85.22 Hyperostosis of skull-Upper arm
0.008 0.991 0.000
M80.5 Idiopathic osteoporosis with pathological fracture
0.009 0.991 0.000
T36.4 Tetracyclines
0.000 0.991 0.008
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.991 0.008
M85.88 Other specified disorders of bone density and structure (Other)
0.008 0.991 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.991 0.008
T36.0 Penicillins
0.000 0.991 0.008
T41.5 Therapeutic gases
0.000 0.991 0.008
T41.4 Anaesthetic, unspecified
0.000 0.991 0.008
T41.3 Local anaesthetics
0.000 0.991 0.008
T41.2 Other and unspecified general anaesthetics
0.000 0.991 0.008
T41.1 Intravenous anaesthetics
0.000 0.991 0.008
T41.0 Inhaled anaesthetics
0.000 0.991 0.008
C82.2 Large cell, follicular
0.000 0.991 0.008
M85.4 Solitary bone cyst
0.008 0.992 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.992 0.008
C91.7 Other lymphoid leukaemia
0.000 0.992 0.008
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.992 0.008
C91.3 Prolymphocytic leukaemia
0.000 0.992 0.008
C91.2 Subacute lymphocytic leukaemia
0.000 0.992 0.008
T48.5 Anti-common-cold drugs
0.000 0.992 0.008
T36.9 Systemic antibiotic, unspecified
0.000 0.992 0.008
T36.8 Other systemic antibiotics
0.000 0.992 0.008
T36.7 Antifungal antibiotics, systemically used
0.000 0.992 0.008
T36.6 Rifamycins
0.000 0.992 0.008
T36.5 Aminoglycosides
0.000 0.992 0.008
T36.2 Chloramphenicol group
0.000 0.992 0.008
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.992 0.008
C93.1 Chronic monocytic leukaemia
0.000 0.992 0.008
M85.20 Hyperostosis of skull-Mult sites
0.008 0.992 0.000
M85.83 Other specified disorders of bone density and structure (Forearm)
0.008 0.992 0.000
C91.9 Lymphoid leukaemia, unspecified
0.000 0.992 0.008
M85.99 Disorder of bone density and structure, unspecified (Site unspecified)
0.008 0.992 0.000
C85.0 Lymphosarcoma
0.000 0.992 0.008
C91.0 Acute lymphoblastic leukaemia
0.000 0.992 0.008
M80.52 Idiopathic osteoporosis with pathological fracture (Upper arm)
0.008 0.992 0.000
M85.87 Other specified disorders of bone density and structure (Ankle and foot)
0.008 0.992 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.992 0.008
M85.69 Other cyst of bone (Site unspecified)
0.008 0.992 0.000
M85.68 Other cyst of bone (Other)
0.008 0.992 0.000
M85.63 Other cyst of bone (Forearm)
0.008 0.992 0.000
M85.62 Other cyst of bone (Upper arm)
0.008 0.992 0.000
M85.61 Other cyst of bone (Shoulder region)
0.008 0.992 0.000
M85.60 Other cyst of bone (Multiple sites)
0.008 0.992 0.000
Y43 Primarily systemic agents
0.000 0.992 0.008
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.992 0.008
M85.29 Hyperostosis of skull-Site unspec
0.008 0.992 0.000
M85.28 Hyperostosis of skull-Other
0.008 0.992 0.000
M85.27 Hyperostosis of skull-Ankle/Foot
0.008 0.992 0.000
M85.26 Hyperostosis of skull-Lower Leg
0.008 0.992 0.000
M85.25 Hyperostosis of skull-Pelvic/Thigh
0.008 0.992 0.000
M85.24 Hyperostosis of skull-Hand
0.008 0.992 0.000
M85.23 Hyperostosis of skull-Forearm
0.008 0.992 0.000
M85.21 Hyperostosis of skull-Shldr region
0.008 0.992 0.000
M80.8 Other osteoporosis with pathological fracture
0.008 0.992 0.000
M83.8 Other adult osteomalacia
0.008 0.992 0.000
T36.3 Macrolides
0.000 0.992 0.007
M85.95 Disorder of bone density and structure, unspecified (Pelvic region and thigh)
0.007 0.992 0.000
M80.9 Unspecified osteoporosis with pathological fracture
0.008 0.992 0.000
M83.3 Adult osteomalacia due to malnutrition
0.007 0.992 0.000
M85.98 Disorder of bone density and structure, unspecified (Other)
0.007 0.992 0.000
M85.00 Fibrous dysplasia (monostotic) (Multiple sites)
0.007 0.992 0.000
M83.9 Adult osteomalacia, unspecified
0.007 0.992 0.000
M43 Other deforming dorsopathies
0.008 0.992 0.000
M85.97 Disorder of bone density and structure, unspecified (Ankle and foot)
0.007 0.992 0.000
M85.96 Disorder of bone density and structure, unspecified (Lower leg)
0.007 0.992 0.000
M85.94 Disorder of bone density and structure, unspecified (Hand)
0.007 0.992 0.000
M85.93 Disorder of bone density and structure, unspecified (Forearm)
0.007 0.992 0.000
M85.92 Disorder of bone density and structure, unspecified (Upper arm)
0.007 0.992 0.000
M85.91 Disorder of bone density and structure, unspecified (Shoulder region)
0.007 0.992 0.000
M85.90 Disorder of bone density and structure, unspecified (Multiple sites)
0.007 0.992 0.000
M43.1 Spondylolisthesis
0.008 0.992 0.000
M80.4 Drug-induced osteoporosis with pathological fracture
0.007 0.992 0.000
M80.3 Postsurgical malabsorption osteoporosis with pathological fracture
0.007 0.992 0.000
M80.2 Osteoporosis of disuse with pathological fracture
0.007 0.992 0.000
M83.5 Other drug-induced osteomalacia in adults
0.007 0.992 0.000
M83.4 Aluminum bone disease
0.007 0.992 0.000
M83.2 Adult osteomalacia due to malabsorption
0.007 0.992 0.000
M83.0 Puerperal osteomalacia
0.007 0.992 0.000
Y43.4 Immunosuppressive agents
0.000 0.993 0.007
M85.84 Other specified disorders of bone density and structure (Hand)
0.007 0.993 0.000
M85.81 Other specified disorders of bone density and structure (Shoulder region)
0.007 0.993 0.000
C91.5 Adult T-cell leukaemia
0.000 0.993 0.007
M85.82 Other specified disorders of bone density and structure (Upper arm)
0.007 0.993 0.000
M85.09 Fibrous dysplasia (monostotic) (Site unspecified)
0.007 0.993 0.000
M85.07 Fibrous dysplasia (monostotic) (Ankle and foot)
0.007 0.993 0.000
M85.06 Fibrous dysplasia (monostotic) (Lower leg)
0.007 0.993 0.000
M85.05 Fibrous dysplasia (monostotic) (Pelvic region and thigh)
0.007 0.993 0.000
M85.04 Fibrous dysplasia (monostotic) (Hand)
0.007 0.993 0.000
M85.03 Fibrous dysplasia (monostotic) (Forearm)
0.007 0.993 0.000
M85.02 Fibrous dysplasia (monostotic) (Upper arm)
0.007 0.993 0.000
M85.01 Fibrous dysplasia (monostotic) (Shoulder region)
0.007 0.993 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.993 0.007
M85.66 Other cyst of bone (Lower leg)
0.007 0.993 0.000
T45.0 Antiallergic and antiemetic drugs
0.000 0.993 0.007
M85.89 Other specified disorders of bone density and structure (Site unspecified)
0.007 0.993 0.000
M82.8 Osteoporosis in other diseases classified elsewhere
0.007 0.993 0.000
M82.0 Osteoporosis in multiple myelomatosis
0.007 0.993 0.000
M82.3 Osteoporosis in diseases classified elsewhere, Forearm
0.007 0.993 0.000
M85.86 Other specified disorders of bone density and structure (Lower leg)
0.007 0.993 0.000
M85.19 Skeletal fluorosis (Site unspecified)
0.007 0.993 0.000
M85.18 Skeletal fluorosis (Other)
0.007 0.993 0.000
M85.17 Skeletal fluorosis (Ankle and foot)
0.007 0.993 0.000
M85.16 Skeletal fluorosis (Lower leg)
0.007 0.993 0.000
M85.15 Skeletal fluorosis (Pelvic region and thigh)
0.007 0.993 0.000
M85.14 Skeletal fluorosis (Hand)
0.007 0.993 0.000
M85.13 Skeletal fluorosis (Forearm)
0.007 0.993 0.000
M85.12 Skeletal fluorosis (Upper arm)
0.007 0.993 0.000
M85.11 Skeletal fluorosis (Shoulder region)
0.007 0.993 0.000
M85.10 Skeletal fluorosis (Multiple sites)
0.007 0.993 0.000
M85.39 Osteitis condensans (Site unspecified)
0.007 0.993 0.000
M85.38 Osteitis condensans (Other)
0.007 0.993 0.000
M85.37 Osteitis condensans (Ankle and foot)
0.007 0.993 0.000
M85.36 Osteitis condensans (Lower leg)
0.007 0.993 0.000
M85.35 Osteitis condensans (Pelvic region and thigh)
0.007 0.993 0.000
M85.34 Osteitis condensans (Hand)
0.007 0.993 0.000
M85.33 Osteitis condensans (Forearm)
0.007 0.993 0.000
M85.32 Osteitis condensans (Upper arm)
0.007 0.993 0.000
M85.31 Osteitis condensans (Shoulder region)
0.007 0.993 0.000
M85.30 Osteitis condensans (Multiple sites)
0.007 0.993 0.000
M85.59 Aneurysmal bone cyst (Site unspecified)
0.007 0.993 0.000
M85.58 Aneurysmal bone cyst (Other)
0.007 0.993 0.000
M85.57 Aneurysmal bone cyst (Ankle and foot)
0.007 0.993 0.000
M85.56 Aneurysmal bone cyst (Lower leg)
0.007 0.993 0.000
M85.55 Aneurysmal bone cyst (Pelvic region and thigh)
0.007 0.993 0.000
M85.54 Aneurysmal bone cyst (Hand)
0.007 0.993 0.000
M85.53 Aneurysmal bone cyst (Forearm)
0.007 0.993 0.000
M85.52 Aneurysmal bone cyst (Upper arm)
0.007 0.993 0.000
M85.51 Aneurysmal bone cyst (Shoulder region)
0.007 0.993 0.000
M85.50 Aneurysmal bone cyst (Multiple sites)
0.007 0.993 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.993 0.007
T45.8 Other primarily systemic and haematological agents
0.000 0.993 0.007
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.993 0.007
T45.6 Fibrinolysis-affecting drugs
0.000 0.993 0.007
T45.5 Anticoagulants
0.000 0.993 0.007
T45.4 Iron and its compounds
0.000 0.993 0.007
T45.3 Enzymes, not elsewhere classified
0.000 0.993 0.007
M85.64 Other cyst of bone (Hand)
0.007 0.993 0.000
M85.08 Fibrous dysplasia (monostotic) (Other)
0.007 0.993 0.000
T47.0 Histamine H(2)-receptor antagonists
0.000 0.993 0.007
M83.1 Senile osteomalacia
0.007 0.993 0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)
0.007 0.993 0.000
M43.19 Spondylolisthesis (Site unspecified)
0.007 0.993 0.000
T38.0 Glucocorticoids and synthetic analogues
0.000 0.993 0.007
C90.1 Plasma cell leukaemia
0.000 0.993 0.007
M43.0 Spondylolysis
0.007 0.993 0.000
M40.2 Other and unspecified kyphosis
0.007 0.993 0.000
T38.9 Other and unspecified hormone antagonists
0.000 0.993 0.006
T38.7 Androgens and anabolic congeners
0.000 0.993 0.006
T38.4 Oral contraceptives
0.000 0.993 0.006
T38.2 Antithyroid drugs
0.000 0.993 0.006
T47.6 Antidiarrhoeal drugs
0.000 0.993 0.006
T45.2 Vitamins, not elsewhere classified
0.000 0.993 0.006
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.993 0.006
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.993 0.006
T47.7 Emetics
0.000 0.993 0.006
T47.5 Digestants
0.000 0.993 0.006
T47.3 Saline and osmotic laxatives
0.000 0.993 0.006
C81.9 Hodgkin's disease, unspecified
0.000 0.993 0.006
M43.6 Torticollis
0.007 0.993 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.993 0.006
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.993 0.006
M80.0 Postmenopausal osteoporosis with pathological fracture
0.006 0.993 0.000
T38.5 Other oestrogens and progestogens
0.000 0.993 0.006
C90.3 Solitary plasmacytoma
0.000 0.993 0.006
M80.59 Idiopathic osteoporosis with pathological fracture (Site unspecified)
0.006 0.994 0.000
M80.58 Idiopathic osteoporosis with pathological fracture (Other)
0.006 0.994 0.000
M80.57 Idiopathic osteoporosis with pathological fracture (Ankle and foot)
0.006 0.994 0.000
M80.56 Idiopathic osteoporosis with pathological fracture (Lower leg)
0.006 0.994 0.000
M80.55 Idiopathic osteoporosis with pathological fracture (Pelvic region and thigh)
0.006 0.994 0.000
M80.54 Idiopathic osteoporosis with pathological fracture (Hand)
0.006 0.994 0.000
M80.53 Idiopathic osteoporosis with pathological fracture (Forearm)
0.006 0.994 0.000
M80.51 Idiopathic osteoporosis with pathological fracture (Shoulder region)
0.006 0.994 0.000
M85.46 Solitary bone cyst (Lower leg)
0.006 0.994 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.994 0.006
M40 Kyphosis and lordosis
0.006 0.994 0.000
M85.49 Solitary bone cyst (Site unspecified)
0.006 0.994 0.000
M85.48 Solitary bone cyst (Other)
0.006 0.994 0.000
M85.44 Solitary bone cyst (Hand)
0.006 0.994 0.000
M85.43 Solitary bone cyst (Forearm)
0.006 0.994 0.000
M85.42 Solitary bone cyst (Upper arm)
0.006 0.994 0.000
M85.41 Solitary bone cyst (Shoulder region)
0.006 0.994 0.000
M85.40 Solitary bone cyst (Multiple sites)
0.006 0.994 0.000
T47.4 Other laxatives
0.000 0.994 0.006
M85.80 Other specified disorders of bone density and structure (Multiple sites)
0.006 0.994 0.000
J02.9 Acute pharyngitis, unspecified
0.000 0.994 0.006
M85.85 Other specified disorders of bone density and structure (Pelvic region and thigh)
0.006 0.994 0.000
M82.1 Osteoporosis in endocrine disorders
0.006 0.994 0.000
M80.88 Other osteoporosis with pathological fracture (Other)
0.006 0.994 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.